⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 67 Billion as Targeted Therapies Drive 6.6% CAGR
globenewswire.com
PFE
MRK
JNJ
LLY
BMY
AZN
REGN
VRTX
RMD
BIIB
GILD
AMGN
ABBV
VERU
Active Pharmaceutical Ingredients (API) Market worth $199.42 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
PFE
ABBV
2026 Takes a Promising Turn in the Fight Against Cancer as Five Advances Offer New Hope
globenewswire.com
JNJ
MRK
MRNA
NTHI
ABBV
AbbVie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations From the U.S. FDA for CRC and NSCLC
prnewswire.com
ABBV
Pharmaceutical Manufacturing Market Size, Share, Trends, and Forecast, 2026-2033 | Biologics and Automation Drive 5.88% CAGR and USD 990.55 Billion Opportunity
globenewswire.com
PFE
JNJ
MRK
LLY
ABBV
TMO
Japan Cell and Gene Therapy Manufacturing Market Forecast to 2035 | Market to Reach USD 5.15 Billion at 29.0% CAGR as Commercial-Scale Capacity and Gene Therapies Expand
globenewswire.com
TMO
CAT
CRL
AMGN
BMY
GILD
AZN
NVS
MRK
JNJ
LLY
ABBV
Global Orphan Drugs Market Size, Share, Trends, and Forecast 2026-2034 | Market to Reach USD 589.2 Billion as Genomics, Precision Medicine, and Regulatory Incentives Drive Growth
globenewswire.com
AMGN
AZN
GNE
GSK
JNJ
MRK
NVS
PFE
SNY
BMY
REGN
BIIB
GILD
ABBV
EXEL
CRSP
NTLA
EDIT
INCY
VRTX
Orphan Drugs - Global Market Size, Share, Industry Trends, and Growth Forecasts, 2025-2031 | Biologics and Asia-Pacific Drive 6.36% CAGR to USD 334.28 Billion
globenewswire.com
ABBV
AMGN
AZN
BMRN
BMY
CSL
GSK
JNJ
NVS
PFE
REGN
SNY
SRPT
VRTX
Parkinson's Disease Market Poised for Expansion During the Forecast Period (2026-2036) Amid JUVMO Approval and Emerging Therapeutic Innovations | DelveInsight
prnewswire.com
ABBV
ANVS
ACIU
BHF
MGNX
NBIX
UCB
Global Immunotherapy Drugs Market - Size, Share, Trends, Competitive Landscape, and Forecast - 2034 | Market to Reach USD 837.14 Billion as Cell Therapies Drive 13.05% CAGR
globenewswire.com
MRK
BMY
NVS
ROG
AMGN
IBIO
AZN
JNJ
GSK
IOVA
ABBV